Imperial Ginseng Products Ltd.
IGPFF
$0.0605
$0.010621.24%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -44.22% | -82.76% | -80.83% | -96.25% | -82.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.22% | -82.76% | -80.83% | -97.48% | -97.41% |
| Operating Income | 44.22% | 82.76% | 80.83% | 97.48% | 86.16% |
| Income Before Tax | -36.55% | -170.26% | -72.22% | -92.41% | 85.33% |
| Income Tax Expenses | -- | -- | -120.70% | -100.00% | -- |
| Earnings from Continuing Operations | -36.55% | -170.26% | 48.44% | -90.14% | 84.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.55% | -170.26% | 48.44% | -90.14% | 84.91% |
| EBIT | 44.22% | 82.76% | 80.83% | 97.48% | 86.16% |
| EBITDA | -- | -- | -- | 99.60% | 90.17% |
| EPS Basic | -38.71% | -171.11% | 48.67% | -90.14% | 86.04% |
| Normalized Basic EPS | -42.11% | -171.43% | 58.93% | 97.21% | 92.49% |
| EPS Diluted | -125.81% | -171.11% | 51.01% | -90.37% | 86.04% |
| Normalized Diluted EPS | -42.11% | -171.43% | 58.93% | 97.21% | 92.49% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 7.60% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 7.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |